Midway Capital Research & Management

Position in JNJ — Johnson & Johnson

CIK 2115416 CHICAGO, IL

Position in JNJ

as of Jun 30, 2026 · filed Jul 14, 2026 Compact

Position Value

$2,227,316

+$104,600 QoQ

Shares Held

8,770

+1.0% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

1.93%

of 13F equity value

Holder Rank

#2,261

of 4,676 holders

Holding Since

Dec 2025

3 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Midway Capital Research & Management holds $3,629,650 across 5 Drug Manufacturers - General names. JNJ ranks #1 (61.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	JNJ	Johnson & Johnson This page	8,770	$2,227,316
2	PFE	Pfizer Inc	50,390	$1,213,391
3	MRK	Merck & Co., Inc.	1,009	$129,656
4	NVS	Novartis AG	363	$56,889
5	LLY	ELI LILLY & Co	2	$2,398

3 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$2,227,316	8,770	+1.0%	Shares	Sole	2026-07-14
2026-03-31	$2,122,716	8,684	+0.3%	Shares	Sole	2026-04-13
2025-12-31	$1,791,566	8,657	—	Shares	Sole	2026-03-03
No filing history on record for this holder in this stock.